基于5-阿赞醇核心的NRAS G12D抑制剂的结构导向开发
Joshua B Cox1, Vinay Nair1, Pijus Mandal1
1Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.
研究人员开发了IACS-56676,这是针对黑色素瘤等癌症中发现的NRAS G12D突变的向治疗. 这种选择性抑制剂为研究NRAS生物学和癌症治疗提供了新的工具.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- NRAS G12D突变驱动黑色素瘤和血液恶性瘤.
- 目前,针对NRAS G12D的向治疗方法有限,这代表着未得到满足的临床需求.
研究的目的:
- 描述一个新型NRAS G12D抑制剂IACS-56676的结构导向发展.
- 建立IACS-56676作为NRAS生物学研究的工具化合物.
- 为了了解NRAS和KRAS蛋白之间的选择性.
主要方法:
- 使用结构导向药物设计原则.
- 化合物的代优化,以提高功效和选择性.
- 生物化学测试以评估对NRAS和KRAS变异的抑制剂活性.
主要成果:
- IACS-56676被确定为NRAS G12D的选择性和强大的抑制剂.
- 关键的结构修改,包括p-循环稳定和Leu 95替代,对于活动至关重要.
- 该抑制剂对野生类型的KRAS和非响应型变体表现出选择性.
结论:
- IACS-56676代表了针对NRAS G12D突变的重大进展.
- 该化合物作为进一步调查NRAS驱动的瘤发生的一个有价值的工具.
- 这项研究为开发选择性RAS抑制剂提供了一个框架.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
11:01Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
Published on: November 23, 2016
相关概念视频
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Preparation of 1° Amines: Gabriel Synthesis
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Preparation of 1° Amines: Azide Synthesis
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
